#USA #New York #Rosen Law Firm #Securities Class Action #Viatris Inc

Rosen Law Firm's Investigation into Viatris Inc.

Rosen Law Firm, a leading global firm focused on investor rights, has announced its ongoing investigation into potential securities claims concerning shareholders of Viatris Inc. (NASDAQ: VTRS). This inquiry arises from allegations that Viatris may have provided materially misleading business information, impacting investor decisions and expectations.

Background of the Case

On February 27, 2025, shortly before the stock market opened, Viatris released its financial results for the fourth quarter and the full year of 2024. Within the press release, an alarming disclosure emerged concerning an inspection conducted in June 2024 at the Indore, India facility responsible for producing Viatris’ oral finished dose products. The investigation revealed that this facility received a warning letter and an import alert from the U.S. Food and Drug Administration (FDA) in December 2024. This action directly affects 11 products being actively distributed, including significant pharmaceuticals like lenalidomide and everolimus.

The disclosure states that while the Indore facility continues to ship products to markets outside the U.S., a negative impact on revenues is anticipated, particularly in Viatris' Antiretroviral (ARV) business in Emerging Markets and select generic products in Europe. Furthermore, the company projected a revenue loss of around $500 million and an impact of approximately $385 million on its adjusted EBITDA for the year 2025.

Following this troubling announcement, Viatris' stock suffered a steep decline, plummeting by 15.2% on the very day the news broke, prompting serious concern among investors.

Action Steps for Investors

For those who purchased shares of Viatris securities, Rosen Law Firm is extending an invitation to join the prospective class action. By participating, investors may recover losses without incurring out-of-pocket fees, thanks to a contingency fee arrangement the firm offers. To inquire further about joining the class action, affected investors can visit this link or contact Phillip Kim, Esq., toll-free, at 866-767-3653.

The Importance of Qualified Legal Counsel

Rosen Law Firm emphasizes the importance of selecting qualified legal representation with a proven track record in securities class actions. Many firms that extend notices may not possess the required experience, resources, or respected standing necessary to effectively litigate such cases. Rosen Law Firm has carved a distinguished path in this domain, representing investors globally with notable success in securities class actions and shareholder derivative litigation.

The firm achieved a historical milestone by securing the largest securities class action settlement against a Chinese company at that time. Moreover, their rankings by ISS Securities Class Action Services reveal a consistent presence in the top echelon of firms handling securities class actions, recovering hundreds of millions for investors over the years.

Conclusion

The current investigation into Viatris Inc. reflects a critical juncture for investors, as misleading business disclosures can have devastating effects on stock prices and shareholder confidence. Rosen Law Firm stands ready to assist those who may have suffered losses related to their investments, ensuring their voices are heard, and rights defended. For ongoing updates, follow the firm on LinkedIn, Twitter, and Facebook.

Attorney Advertising: Prior results are not indicative of future outcomes.